Stotles logo
Closed

Suministro de medicamentos antineoplásicos, anticuerpos monoclonales (Subgrupo terapéutico L01XC)

Published

Description

Suministro de medicamentos antineoplásicos, anticuerpos monoclonales (Subgrupo terapéutico L01XC) Lot 1: Cetuximab 5mg/ml Vial Cetuximab 5mg/ml Vial Lot 10: Trastuzumab Emtansina 160 mg Vial Trastuzumab Emtansina 160 mg Vial Lot 11: Obinutuzumab 1000 mg Vial Obinutuzumab 1000 mg Vial Lot 12: Nivolumab 10 mg/ml Vial Nivolumab 10 mg/ml Vial Lot 13: Pembrolizumab 25 mg/ml Vial Pembrolizumab 25 mg/ml Vial Lot 14: Ramucirumab 10mg/ml Vial Ramucirumab 10mg/ml Vial Lot 15: Daratumumab 20mg /ml Vial Daratumumab 20mg /ml Vial Lot 16: Daratumumab 1800 mg Vial Daratumumab 1800 mg Vial Lot 17: Inotuzumab Ozogamicina 1 mg Vial Inotuzumab Ozogamicina 1 mg Vial Lot 18: Durvalumab Imfinzi 50 mg/ml Vial Durvalumab Imfinzi 50 mg/ml Vial Lot 19: Avelumab 20 mg/ml Vial Avelumab 20 mg/ml Vial Lot 2: Rituximab 1400 mg Vial Rituximab 1400 mg Vial Lot 20: Atezolizumab 1200 mg Vial Atezolizumab 1200 mg Vial Lot 3: Trastuzumab 600 Mg Vial Trastuzumab 600 Mg Vial Lot 4: Gemtuzumab Ozogamicina 5mg Vial Gemtuzumab Ozogamicina 5mg Vial Lot 5: Panitumumab 20mg/ml Vial Panitumumab 20mg/ml Vial Lot 6: Ipilimumab 5mg/ml Vial Ipilimumab 5mg/ml Vial Lot 7: Brentuximab 50 mg Vial Brentuximab 50 mg Vial Lot 8: Pertuzumab 420 mg Vial Pertuzumab 420 mg Vial Lot 9: Trastuzumab Emtansina 100 mg Vial Trastuzumab Emtansina 100 mg Vial Lot 1: Cetuximab 5mg/ml Vial Cetuximab 5mg/ml Vial Lot 10: Trastuzumab Emtansina 160 mg Vial Trastuzumab Emtansina 160 mg Vial Lot 11: Obinutuzumab 1000 mg Vial Obinutuzumab 1000 mg Vial Lot 12: Nivolumab 10 mg/ml Vial Nivolumab 10 mg/ml Vial Lot 13: Pembrolizumab 25 mg/ml Vial Pembrolizumab 25 mg/ml Vial Lot 14: Ramucirumab 10mg/ml Vial Ramucirumab 10mg/ml Vial Lot 15: Daratumumab 20mg /ml Vial Daratumumab 20mg /ml Vial Lot 16: Daratumumab 1800 mg Vial Daratumumab 1800 mg Vial Lot 17: Inotuzumab Ozogamicina 1 mg Vial Inotuzumab Ozogamicina 1 mg Vial Lot 18: Durvalumab Imfinzi 50 mg/ml Vial Durvalumab Imfinzi 50 mg/ml Vial Lot 19: Avelumab 20 mg/ml Vial Avelumab 20 mg/ml Vial Lot 2: Rituximab 1400 mg Vial Rituximab 1400 mg Vial Lot 20: Atezolizumab 1200 mg Vial Atezolizumab 1200 mg Vial Lot 3: Trastuzumab 600 Mg Vial Trastuzumab 600 Mg Vial Lot 4: Gemtuzumab Ozogamicina 5mg Vial Gemtuzumab Ozogamicina 5mg Vial Lot 5: Panitumumab 20mg/ml Vial Panitumumab 20mg/ml Vial Lot 6: Ipilimumab 5mg/ml Vial Ipilimumab 5mg/ml Vial Lot 7: Brentuximab 50 mg Vial Brentuximab 50 mg Vial Lot 8: Pertuzumab 420 mg Vial Pertuzumab 420 mg Vial Lot 9: Trastuzumab Emtansina 100 mg Vial Trastuzumab Emtansina 100 mg Vial

Timeline

Close date

3 years ago

Publish date

3 years ago

Buyer information

Subsecretaría de la Consellería de Sanidad y Salud Pública

Contact:
Subsecretaría de la Consellería de Sanidad y Salud Pública
Email:
sac_san@gva.es

Explore contracts and tenders relating to Subsecretaría de la Consellería de Sanidad y Salud Pública

Go to buyer profile
To save this opportunity, sign up to Stotles for free.
Save in app
  • Looking glass on top of a file iconTender tracking

    Access a feed of government opportunities tailored to you, in one view. Receive email alerts and integrate with your CRM to stay up-to-date.

  • ID card iconProactive prospecting

    Get ahead of competitors by reaching out to key decision-makers within buying organisations directly.

  • Open folder icon360° account briefings

    Create in-depth briefings on buyer organisations based on their historical & upcoming procurement activity.

  • Teamwork iconCollaboration tools

    Streamline sales workflows with team collaboration and communication features, and integrate with your favourite sales tools.

Stop chasing tenders, start getting ahead.

Create your free feed

Explore similar tenders and contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

Explore more suppliers to Subsecretaría de la Consellería de Sanidad y Salud Pública

Sign up